3-Jan-2025
No headlines found.
Globe Newswire (Wed, 13-Nov 7:00 AM ET)
Globe Newswire (Wed, 6-Nov 7:00 AM ET)
Kamada to Present at the Stifel 2024 Healthcare Conference
Globe Newswire (Mon, 4-Nov 7:00 AM ET)
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Kamada Ltd. - trades on the NASDAQ stock market under the symbol KMDA.
As of January 3, 2025, KMDA stock price climbed to $6.45 with 17,591 million shares trading.
KMDA has a beta of 0.90, meaning it tends to be less sensitive to market movements. KMDA has a correlation of 0.10 to the broad based SPY ETF.
KMDA has a market cap of $370.71 million. This is considered a Small Cap stock.
Last quarter Kamada Ltd. - reported $42 million in Revenue and $.07 earnings per share. This beat revenue expectation by $820,000 and met earnings estimates .
In the last 3 years, KMDA traded as high as $6.88 and as low as $3.72.
The top ETF exchange traded funds that KMDA belongs to (by Net Assets): DFIS, DFIC, DFAX.
KMDA has underperformed the market in the last year with a return of +5.7%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in KMDA shares. However, KMDA has outperformed the market in the last 3 month and 2 week periods, returning +24.8% and +9.3%, while SPY returned +4.6% and +0.1%, respectively. This indicates KMDA has been having a stronger performance recently.
KMDA support price is $6.19 and resistance is $6.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KMDA shares will trade within this expected range on the day.